Insulin resistance is associated with the metabolic syndrome and is not directly linked to coronary artery disease

被引:11
|
作者
Vonbank, Alexander [1 ,2 ,3 ]
Saely, Christoph H. [1 ,2 ,3 ]
Rein, Philipp [1 ,2 ,3 ]
Beer, Stefan [1 ,2 ,3 ]
Breuss, Johannes [1 ,3 ]
Boehnel, Christian [1 ,3 ]
Drexel, Heinz [1 ,2 ,3 ,4 ]
机构
[1] Vorarlberg Inst Vasc Invest & Treatment VIVIT, A-6807 Feldkirch, Austria
[2] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria
[3] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[4] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
关键词
Insulin resistance; HOMA index; Metabolic syndrome; Coronary artery disease; Coronary atherosclerosis; Coronary angiography; Atherothrombosis; TREATMENT PANEL-III; INTERNATIONAL DIABETES FEDERATION; HOMEOSTASIS MODEL ASSESSMENT; CARDIOVASCULAR-DISEASE; NONDIABETIC PATIENTS; ANGIOGRAPHIC SEVERITY; DIAGNOSTIC-CRITERIA; RISK; ATHEROSCLEROSIS; CHOLESTEROL;
D O I
10.1016/j.cca.2011.02.008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Insulin resistance (IR) is the key feature of the metabolic syndrome (MetS). Its association with directly visualized coronary atherosclerosis is unclear. We hypothesised that insulin resistance is associated with both angiographically determined coronary artery disease (CAD) and with the MetS. Methods: In 986 consecutive patients undergoing coronary angiography for the evaluation CAD. IR was determined by the HOMA index; the MetS was defined according to NCEP-ATPIII criteria; and significant CAD was diagnosed when coronary stenoses >= 50% were present. Results: HOMA IR scores were higher in MetS patients than in subjects without the MetS (4.9 +/- 6.4 vs. 2.2 +/- 2.0; p < 0.001). HOMA IR did not differ significantly between patients with significant CAD and those who did not have significant CAD. When both, the presence of MetS and of significant CAD were considered, HOMA IR was significantly higher in patients with the MetS both among those who had significant CAD (4.9 +/- 6.8 vs. 2.2 +/- 1.8; p < 0.001) and among those who did not have significant CAD (5.0 +/- 5.8 vs. 2.1 +/- 2.3; p < 0.001), it did not differ significantly between patients with significant CAD and subjects without significant CAD among patients with the MetS nor among those without MetS. Similar results were obtained with the IDF definition of the MetS. Conclusion: IR is significantly associated with the MetS but not with angiographically determined CAD. IR may play a greater role in the eventual precipitation of thrombosis than in the gradual progression of atherosclerosis. (C) 2011 Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:1003 / 1007
页数:5
相关论文
共 50 条
  • [21] Impact of pemafibrate on lipid profile and insulin resistance in hypertriglyceridemic patients with coronary artery disease and metabolic syndrome
    Nakamura, Akihiro
    Kagaya, Yuta
    Saito, Hiroki
    Kanazawa, Masanori
    Sato, Kenjiro
    Miura, Masanobu
    Kondo, Masateru
    Endo, Hideaki
    HEART AND VESSELS, 2024, 39 (06) : 486 - 495
  • [22] Impact of pemafibrate on lipid profile and insulin resistance in hypertriglyceridemic patients with coronary artery disease and metabolic syndrome
    Akihiro Nakamura
    Yuta Kagaya
    Hiroki Saito
    Masanori Kanazawa
    Kenjiro Sato
    Masanobu Miura
    Masateru Kondo
    Hideaki Endo
    Heart and Vessels, 2024, 39 : 486 - 495
  • [23] Insulin resistance is associated with the metabolic syndrome but not with peripheral arterial disease
    Vonbank, A.
    Saely, C. H.
    Rein, P.
    Boehnel, C.
    Jankovic, V.
    Breuss, J.
    Greber, S.
    Drexel, H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 : 55 - 55
  • [24] Insulin Resistance Is Associated with the Metabolic Syndrome but Not with Peripheral Arterial Disease
    Vonbank, Alexander
    Saely, Christoph H.
    Rein, Philipp
    Boehnel, Christian
    Kiene, Veronika
    Drexel, Veronika
    Greber, Susanne
    Drexel, Heinz
    DIABETES, 2011, 60 : A651 - A652
  • [25] INSULIN RESISTANCE IS ASSOCIATED WITH THE METABOLIC SYNDROME BUT NOT WITH PERIPHERAL ARTERIAL DISEASE
    Vonbank, A.
    Saely, C. H.
    Rein, P.
    Boehnel, C.
    Greber, S.
    Drexel, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 17 - 17
  • [26] Insulin resistance and coronary artery disease
    Bressler, P
    Bailey, SR
    Matsuda, M
    DeFronzo, RA
    DIABETOLOGIA, 1996, 39 (11) : 1345 - 1350
  • [27] Metabolic Syndrome Associates With Resistance to Aspirin in Patients With Coronary Artery Disease
    Smith, James P.
    Haddad, Elias V.
    Boutaud, Olivier
    Oram, Denise A.
    Blakemore, Dana L.
    Chen, Qingxia
    Taylor, Mary B.
    Oates, John A.
    CIRCULATION, 2009, 120 (18) : S1033 - S1033
  • [28] Metabolic syndrome and coronary artery disease
    Fiuza, Manuela
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (12) : 779 - 782
  • [29] INSULIN RESISTANCE, HYPERINSULINEMIA, AND CORONARY-ARTERY DISEASE - A COMPLEX METABOLIC WEB
    DEFRONZO, RA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S1 - S16
  • [30] 'True' fasting serum insulin level, insulin resistance syndrome and coronary artery disease
    Chaour, M
    Théroux, P
    Gilfix, BM
    Campeau, L
    Lespérance, J
    Ghitescu, M
    Gélinas, F
    Solymoss, BC
    CORONARY ARTERY DISEASE, 1997, 8 (11-12) : 683 - 688